Tag: Cancer: Prostate
PSA Screening Tied to Lower Risk for Prostate Cancer Mortality
Annual screening may be particularly important for Black men
ADT Use for Prostate Cancer Linked to Increased Risk for CVD Death
Risk increased for CVD death and for death from ischemic heart disease and stroke, especially among those aged 70 to 79 years
Healthy Lifestyle Cuts Prostate Cancer Mortality Among High-Risk Men
Lifestyle factors not tied to overall diagnosis of prostate cancer
Enzalutamide Active in Low-, Intermediate-Risk Prostate Cancer
Significant reduction seen in risk of prostate cancer progression for enzalutamide plus AS versus active surveillance alone
Higher Dairy Intake May Up Risk for Prostate Cancer
However, association does not hold for nondairy calcium intake
ADT + Pelvic Lymph Node Radiation Improves Prostate Cancer Outcomes
Five-year freedom from progression rate higher for those receiving short-term ADT and PLNRT in addition to salvage PBRT
AE Risk Examined for Abiraterone, Enzalutamide in Prostate Cancer
Risk for metabolic or cardiovascular adverse events increased for men receiving abiraterone or enzalutamide for advanced disease
KangDuo Surgical Robot-01 System Feasible for Radical Prostatectomy
Evaluation shows safety and effectiveness for the management of localized prostate cancer
AUA: Pandemic Disruptions Impacted One in Four Prostate, Bladder Cancer Patients
Changes, delays, and cancellation of cancer treatment and ancillary care reported
Orteronel Misses Goal in Metastatic Hormone-Sensitive Prostate Cancer
Significant improvement seen in progression-free survival, but not overall survival, with addition of orteronel to androgen deprivation therapy
